Brown Advisory’s KALA BIO KALA Stock Holding History

Brown Advisory’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-80	Closed	-$527K	–	1263
2021 Q3	$527K	Hold	80	–	–	﹤0.01%	817
2021 Q2	$1.06M	Hold	80	–	–	﹤0.01%	692
2021 Q1	$1.35M	Hold	80	–	–	﹤0.01%	647
2020 Q4	$1.36M	Hold	80	–	–	﹤0.01%	600
2020 Q3	$1.51M	Hold	80	–	–	﹤0.01%	548
2020 Q2	$2.11M	Sell	80 -4	-5%	-$113K	﹤0.01%	494
2020 Q1	$1.85M	Hold	84	–	–	0.01%	485
2019 Q4	$779K	Hold	84	–	–	﹤0.01%	685
2019 Q3	$803K	Hold	84	–	–	﹤0.01%	659
2019 Q2	$1.35M	Hold	84	–	–	﹤0.01%	595
2019 Q1	$1.75M	Hold	84	–	–	﹤0.01%	665
2018 Q4	$1.03M	Hold	84	–	–	﹤0.01%	762
2018 Q3	$2.08M	Hold	84	–	–	0.01%	631
2018 Q2	$2.9M	Sell	84 -16	-16%	-$614K	0.01%	553
2018 Q1	$3.96M	Buy	+100	New	+$3.8M	0.01%	428

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAFP

Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Advisory's KALA Position: Q4 2021 in Review

Brown Advisory sold out of KALA BIO (KALA) in Q4 2021, closing a stake of 80 shares — an estimated $527K sold.

Brown Advisory first reported a position in KALA in Q1 2018 and held it in 15 quarters. The position peaked at $3.96M in Q1 2018. 79 funds tracked by Wall St. Rank hold KALA as of Q4 2021.

Brown Advisory reported no remaining KALA BIO position as of Q4 2021 after selling out during the quarter.
Brown Advisory sold 80 KALA BIO shares in Q4 2021, an estimated $527K.
Brown Advisory first reported a position in KALA BIO in Q1 2018 and held it in 15 quarters.
Brown Advisory's KALA BIO position peaked at $3.96M in Q1 2018.
79 funds tracked by Wall St. Rank held KALA BIO as of Q4 2021.

Based on Brown Advisory's 13F filing for Q4 2021, filed 27 Jan 2022.